#FutureReadyHealthcare

Who We Are
Investor Relations
News
Careers
Indegene

Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies

Back to Videos

Related Insights

5:36

XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina

1:01:37

Webinar: The Metaverse - What it means for life sciences companies